Perfromance Wealth Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $712K | Sell |
1,600
-3
| -0.2% | -$1.34K | 0.02% | 86 |
|
|
2025
Q1 | $777K | Hold |
1,603
| – | – | 0.03% | 70 |
|
|
2024
Q4 | $646K | Sell |
1,603
-13
| -0.8% | -$5.24K | 0.02% | 84 |
|
|
2024
Q3 | $752K | Buy |
1,616
+16
| +1% | +$7.44K | 0.03% | 78 |
|
|
2024
Q2 | $750K | Hold |
1,600
| – | – | 0.03% | 65 |
|
|
2024
Q1 | $669K | Hold |
1,600
| – | – | 0.03% | 79 |
|
|
2023
Q4 | $651K | Hold |
1,600
| – | – | 0.03% | 85 |
|
|
2023
Q3 | $556K | Hold |
1,600
| – | – | 0.03% | 97 |
|
|
2023
Q2 | $557K | Buy |
1,600
+400
| +33% | +$139K | 0.03% | 104 |
|
|
2023
Q1 | $378K | Buy |
1,200
+400
| +50% | +$126K | 0.02% | 132 |
|
|
2022
Q4 | $231K | Buy |
+800
| New | +$231K | 0.01% | 149 |
|